BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8596826)

  • 1. Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy.
    Helvie MA; Joynt LK; Cody RL; Pierce LJ; Adler DD; Merajver SD
    Radiology; 1996 Feb; 198(2):327-32. PubMed ID: 8596826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of mammography in breast preservation in locally advanced breast cancer.
    Pierce L; Adler D; Helvie M; Lichter A; Merajver S
    Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):571-7. PubMed ID: 8621280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients.
    Croshaw R; Shapiro-Wright H; Svensson E; Erb K; Julian T
    Ann Surg Oncol; 2011 Oct; 18(11):3160-3. PubMed ID: 21947594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation.
    Vinnicombe SJ; MacVicar AD; Guy RL; Sloane JP; Powles TJ; Knee G; Husband JE
    Radiology; 1996 Feb; 198(2):333-40. PubMed ID: 8596827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy.
    Peintinger F; Kuerer HM; Anderson K; Boughey JC; Meric-Bernstam F; Singletary SE; Hunt KK; Whitman GJ; Stephens T; Buzdar AU; Green MC; Symmans WF
    Ann Surg Oncol; 2006 Nov; 13(11):1443-9. PubMed ID: 17028770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.
    Chagpar AB; Middleton LP; Sahin AA; Dempsey P; Buzdar AU; Mirza AN; Ames FC; Babiera GV; Feig BW; Hunt KK; Kuerer HM; Meric-Bernstam F; Ross MI; Singletary SE
    Ann Surg; 2006 Feb; 243(2):257-64. PubMed ID: 16432360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy.
    Marinovich ML; Houssami N; Macaskill P; Sardanelli F; Irwig L; Mamounas EP; von Minckwitz G; Brennan ME; Ciatto S
    J Natl Cancer Inst; 2013 Mar; 105(5):321-33. PubMed ID: 23297042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy.
    Patel BK; Hilal T; Covington M; Zhang N; Kosiorek HE; Lobbes M; Northfelt DW; Pockaj BA
    Ann Surg Oncol; 2018 May; 25(5):1350-1356. PubMed ID: 29516362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?
    Jochelson MS; Lampen-Sachar K; Gibbons G; Dang C; Lake D; Morris EA; Morrow M
    Ann Surg Oncol; 2015 May; 22(5):1490-5. PubMed ID: 25777093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer.
    Keune JD; Jeffe DB; Schootman M; Hoffman A; Gillanders WE; Aft RL
    Am J Surg; 2010 Apr; 199(4):477-84. PubMed ID: 20359567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of response by breast helical computed tomography to neoadjuvant chemotherapy in large inflammatory breast cancer.
    Moyses B; Haegele P; Rodier JF; Lehmann S; Petit T; Velten M; Schraub S
    Clin Breast Cancer; 2002 Jan; 2(4):304-10. PubMed ID: 11899363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic correlation of residual mammographic microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer.
    Adrada BE; Huo L; Lane DL; Arribas EM; Resetkova E; Yang W
    Ann Surg Oncol; 2015 Apr; 22(4):1111-7. PubMed ID: 25287438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy.
    Belli P; Costantini M; Malaspina C; Magistrelli A; LaTorre G; Bonomo L
    Clin Radiol; 2006 Nov; 61(11):946-53. PubMed ID: 17018307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer.
    Bassa P; Kim EE; Inoue T; Wong FC; Korkmaz M; Yang DJ; Wong WH; Hicks KW; Buzdar AU; Podoloff DA
    J Nucl Med; 1996 Jun; 37(6):931-8. PubMed ID: 8683314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MR-mammography assessment of tumor response after neoadjuvant radiochemotherapy of locally advanced breast carcinoma].
    Kurtz B; Achten C; Audretsch W; Rezai M; Urban P; Zocholl G
    Rofo; 1996 Jun; 164(6):469-74. PubMed ID: 8688503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locally advanced breast carcinoma: evaluation of mammography in the prediction of residual disease after induction chemotherapy.
    Huber S; Wagner M; Zuna I; Medl M; Czembirek H; Delorme S
    Anticancer Res; 2000; 20(1B):553-8. PubMed ID: 10769724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvant chemotherapy in breast cancer.
    Livi L; Saieva C; Borghesi S; De Luca Cardillo C; Scotti V; Mangoni M; Greto D; Cataliotti L; Paiar F; Bianchi S; Biti GP
    J Chemother; 2009 Nov; 21(5):558-65. PubMed ID: 19933048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative taxane-based chemotherapy in a standardized protocol for locally advanced breast cancer.
    Chan A; Willsher PC; Hastrich DJ; Anderson J; Barham T; Latham B; Redfern A; VAN DER Schaaf A; Thomson J; Joseph D; Ingram D
    Asia Pac J Clin Oncol; 2012 Mar; 8(1):62-70. PubMed ID: 22369445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do Calcifications Seen on Mammography After Neoadjuvant Chemotherapy for Breast Cancer Always Need to Be Excised?
    Feliciano Y; Mamtani A; Morrow M; Stempel MM; Patil S; Jochelson MS
    Ann Surg Oncol; 2017 Jun; 24(6):1492-1498. PubMed ID: 28058550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic tumor response of invasive lobular carcinoma to neo-adjuvant chemotherapy.
    Joh JE; Esposito NN; Kiluk JV; Laronga C; Khakpour N; Soliman H; Catherine Lee M
    Breast J; 2012; 18(6):569-74. PubMed ID: 23034096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.